These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33269892)

  • 21. Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial.
    Asrani S; Robin AL; Serle JB; Lewis RA; Usner DW; Kopczynski CC; Heah T;
    Am J Ophthalmol; 2019 Nov; 207():248-257. PubMed ID: 31229466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.
    Bhargava M; Sen S; Bhambhani V; Paul RS; Dutta C
    Indian J Ophthalmol; 2022 Apr; 70(4):1163-1170. PubMed ID: 35326007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
    Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
    Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of pseudophakic bullous keratopathy by combined Descemet-stripping endothelial keratoplasty and intraocular lens exchange.
    Wylegała E; Tarnawska D
    J Cataract Refract Surg; 2008 Oct; 34(10):1708-14. PubMed ID: 18812122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of corneal endothelial and graft survival in pseudophakic bullous keratopathy.
    Sugar A
    Trans Am Ophthalmol Soc; 1989; 87():762-801. PubMed ID: 2562532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.
    Jeang LJ; Shah AS; Hammer JD; Tuli SS
    Digit J Ophthalmol; 2022; 28(8):34-37. PubMed ID: 35854963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reticular corneal epithelial edema with topical netarsudil.
    Parmar DP; Bhole PK; Garde PV
    Oman J Ophthalmol; 2023; 16(1):94-97. PubMed ID: 37007228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
    Hoy SM
    Drugs; 2018 Mar; 78(3):389-396. PubMed ID: 29453668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive corneal clearance after a DMEK graft partially folded over on itself in a non-fuchs pseudophakic eye.
    Ponce de Los Ríos CD; Gris O; Elies D; Güell JL
    Cornea; 2014 Sep; 33(9):985-7. PubMed ID: 25062333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy.
    Lindstrom RL; Lewis AE; Holland EJ; Sheppard JD; Hovanesian JA; Senchyna M; Hollander DA
    J Ocul Pharmacol Ther; 2022 Dec; 38(10):657-663. PubMed ID: 36327101
    [No Abstract]   [Full Text] [Related]  

  • 31. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
    Koizumi N; Okumura N; Ueno M; Kinoshita S
    Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Ripasudil for the Treatment of Segmental Corneal Edema: A Case Series.
    Tseng M; Feder R
    Cornea; 2023 Jul; 42(7):903-907. PubMed ID: 37098107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension.
    Kopczynski CC; Heah T
    Drugs Today (Barc); 2018 Aug; 54(8):467-478. PubMed ID: 30209441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early results of small-incision Descemet's stripping and automated endothelial keratoplasty.
    Koenig SB; Covert DJ
    Ophthalmology; 2007 Feb; 114(2):221-6. PubMed ID: 17156845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Kogo J; Tokuda N; Takagi H
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):4. PubMed ID: 34982146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex deep lamellar endothelial keratoplasty for complex bullous keratopathy with severe vision loss.
    Huang T; Wang Y; Gao N; Wang T; Ji J; Chen J
    Cornea; 2009 Feb; 28(2):157-62. PubMed ID: 19158557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical outcomes of endothelial keratoplasty safety-basket suture for management of difficult cases.
    Behshad S; Wade M; Farid M; Garg S
    Can J Ophthalmol; 2019 Dec; 54(6):746-750. PubMed ID: 31836110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Clinical Impact of Netarsudil 0.02% at an Urban Safety-Net Hospital.
    Fridman G; Sadlak N; Eliassi-Rad B; Desai MA
    J Ocul Pharmacol Ther; 2021; 37(6):338-342. PubMed ID: 33983847
    [No Abstract]   [Full Text] [Related]  

  • 39. Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
    Lin CW; Sherman B; Moore LA; Laethem CL; Lu DW; Pattabiraman PP; Rao PV; deLong MA; Kopczynski CC
    J Ocul Pharmacol Ther; 2018; 34(1-2):40-51. PubMed ID: 28609185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netarsudil-associated epithelial keratopathy.
    Ramakrishnan MS; Addis VM; Lehman AY; Sankar PS
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100800. PubMed ID: 32637736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.